Zhitong Finance App News, Sinopharm Hyundai (600420.SH) issued an announcement. Recently, Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. (Sinopharm Rongsheng for short), a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for bisoprolol amlodipine tablets approved and issued by the China Drug Administration. As an alternative treatment for hypertension, bisoprolol amlodipine tablets are suitable for patients currently taking the same single dose as the compound preparation and have good blood pressure control.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.